首页> 外文期刊>Pediatric Hematology Oncology Journal >Effect of rituximab added to standard chemotherapy on minimal residual disease during induction in cd-20 positive pediatric acute lymphoblastic leukemia (ALL): a randomised controlled pilot trial
【24h】

Effect of rituximab added to standard chemotherapy on minimal residual disease during induction in cd-20 positive pediatric acute lymphoblastic leukemia (ALL): a randomised controlled pilot trial

机译:标准化疗中加入利妥昔单抗对CD-20阳性小儿急性淋巴细胞性白血病(ALL)诱导期间最小残留疾病的影响:一项随机对照试验

获取原文
           

摘要

Children with non-burkitt NHL had good outcome. Advanced disease, hypoalbumineamia and high tumour burden at the time of diag- nosis were associated with poor survival. Result: Based on the results of the bone marrow examination, cyto- chemistry and flow cytometry both the cases were diagnosed as SBB positive Acute lymphoblastic leukaemia.
机译:非Burkitt NHL的儿童预后良好。诊断时晚期疾病,低白蛋白血症和高肿瘤负荷与不良的生存率相关。结果:根据骨髓检查,细胞化学和流式细胞术的结果,这两个病例均被诊断为SBB阳性急性急性淋巴细胞白血病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号